SBI Healthcare Opportunities Fund Regular Growth is a Sector - Healthcare mutual fund scheme from SBI Funds Management Ltd. The fund was launched on 31 December 2004 and is managed by Tanmaya Desai. As of 15 October 2026, the fund has an AUM of ₹5,870.00 Cr and its latest NAV is ₹487.33. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹500 and lumpsum investment starting from ₹5,000.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Acutaas Chemicals Ltd, Apollo Hospitals Enterprise Ltd, and Torrent Pharmaceuticals Ltd. The fund has delivered 13.1% returns over the last 1 year, 20.5% annualised returns over 3 years, 15.8% annualised returns over 5 years, and 15.3% annualised returns since inception.
SBI Healthcare Opportunities Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






